Medicinski Glasnik最新文献

{"title":"Restoration of the function of the sciatic nerve and its branches after trauma.","authors":"Alimkhan Khalimov, Yermek Dyussembekov, Marat Mirzabaev, Marat Aliyev, Nursultan Abilkhanov, Daniyar Bayezov, Saule Iskakova, Aigul Tazhiyeva","doi":"10.17392/1849-22-01","DOIUrl":"https://doi.org/10.17392/1849-22-01","url":null,"abstract":"<p><strong>Aim: </strong>To investigate the efficacy of various methods for restoring the sciatic nerve and its branches after traumatic injuries to develop optimal treatment strategies, improve functional outcomes, and enhance patients' quality of life.</p><p><strong>Methods: </strong>A retrospective cohort study was conducted at the Neurosurgical Centre of Almaty, Kazakhstan, based on City Clinical Hospital No. 7. From 2013 to 2022, 227 patients with sciatic nerve lesions and their branches were operated. The proportion of patients of working age was 93.8%. Over half of the patients were hospitalized more than six months after the injury.</p><p><strong>Results: </strong>A high and satisfactory level of functional recovery after the surgical treatment of the sciatic nerve and its branches was achieved in 173 (77.5%) patients, with partial improvement in 21 (9.4%) and no significant improvement in 30 (13.1%). Two-stage restoration of the sciatic nerve function in cases with diastasis of more than 5 cm improved treatment results in 202 (89.2%) patients contributing to the restoration of motor function and gait within two to three years.</p><p><strong>Conclusion: </strong>When repairing the sciatic nerve with extensive defects, the tibial nerve is prioritized over the peroneal nerve due to better regeneration. Nerve autoplasty is preferred because of the rigidity of the sciatic nerve trunk and significant muscle load. For diastasis over 7 cm, the peroneal nerve trunk can be used for tibial nerve plasty. Two-stage reconstruction involves tendon-muscle plasty after signs of tibial nerve conduction appear, restoring motor function and gait and improving the patient's quality of life.</p>","PeriodicalId":51129,"journal":{"name":"Medicinski Glasnik","volume":"22 1","pages":"88-96"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143702122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Lower urinary tract symptoms (LUTS) as a clinical feature of lumbar spinal stenosis (LSS): a prospective study with lumbar spine morphometry analysis.","authors":"Harun Hodžić, Hakija Bečulić, Emir Begagić, Nejla Huseinspahić, Igor Sladojević, Andrej Popov, Rasim Iriškić, Tarik Zulović, Emir Bećirović, Goran Lakičević, Adem Nuhović, Haso Sefo, Aldin Jusić, Jovana Radovanović","doi":"10.17392/1858-22-01","DOIUrl":"https://doi.org/10.17392/1858-22-01","url":null,"abstract":"<p><strong>Aim: </strong>To investigate clinical and morphometric characteristics of patients with lower urinary tract symptoms (LUTS) due to lumbar spinal stenosis (LSS).</p><p><strong>Methods: </strong>This study evaluated LSS patients using clinical assessments of motor, sensory, bladder, and bowel functions, and functional disability scores from the Oswestry Disability Index (ODI) and Swiss Spinal Stenosis Questionnaire (SSSQ). Morphometric analysis included MRI measurements of the anteroposterior diameter of the intervertebral disc and dural sac, and the modified Torg-Pavlov ratio (mTPR), with follow-up re-evaluations at 6 months.</p><p><strong>Results: </strong>Of 159 patients, 49 (30.8%) had LUTS and 110 (69.2%) were in the control group. LUTS patients had a significantly higher prevalence of neurogenic claudication (100% vs. 47.3%; p<0.001), lower back pain (93.9% vs. 77.3%; p=0.011), and lower extremity pain (57.1% vs. 34.5%; p=0.008). The LUTS group also had higher ODI (54.0 vs. 50.0; p=0.019) and SSSQ score (44.0 vs. 34.0; p<0.001). Morphometric analysis showed significantly lower mTPR in LUTS patients (median 0.31 vs. 0.45; p<0.001), with an AUC of 0.704 (95%CI 0.627-0.774). mTPR ≤0.31 predicted surgical revision within 6 months (OR:3.4, CI: 1.2-9.8), motor deficiency (OR:2.1, 95%CI: 1.4-5.2), and persistent LUTS post-surgery (OR:4.5, 95%CI: 1.1-18.9). mTPR ≤0.34 was associated with worse follow-up outcome, including increased ODI (β:3.2; 95%CI: 1.1-5.3; p=0.004) and SSSQ score (β:4.8; 95%CI:2.1-7.5).</p><p><strong>Conclusion: </strong>LUTS patients with LSS exhibit more severe symptoms and poorer outcome, with mTPR ≤0.34 being a predictor of adverse clinical outcome and the need for surgical revision within 6 months.</p>","PeriodicalId":51129,"journal":{"name":"Medicinski Glasnik","volume":"22 1","pages":"104-110"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143702116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Enhancing perioperative planning: three-dimensional printing templating in orthopaedic surgery.","authors":"Domy Pradana Putra, Edi Mustamsir, Krisna Yuarno Phatama, Ananto Satya Pradana, Felix Cendikiawan","doi":"10.17392/1901-22-01","DOIUrl":"https://doi.org/10.17392/1901-22-01","url":null,"abstract":"<p><strong>Aim: </strong>3D printing technology revolutionises orthopaedic surgery by creating accurate patient-specific models, surgical guides, and implants. The COVID-19 pandemic accelerated this trend, allowing localized solutions and biocompatible materials to replicate bone geometric complexity, enabling surgeons to plan and rehearse surgeries. This study aims to illustrate the use of 3D printing in the preoperative planning of a complex distal femur fracture.</p><p><strong>Methods: </strong>A 42-year-old woman with a complicated Gustilo-Anderson grade III-A fracture underwent 3D printing for implant planning, contouring, and screw trajectory visualization. The procedure took seven hours, and the surgery lasted only two hours, with no complications or complaints during a one-month follow-up.</p><p><strong>Results: </strong>3D printing has revolutionized orthopaedic surgery by better visualizing complex fractures, reducing surgical time, and enhancing precision. Traditional 2D imaging techniques struggle to capture intricate details, requiring 3D printing for accurate preoperative planning and implant selection. However, challenges include high costs, time, and specialized training. Further research is needed to understand long-term outcomes.</p><p><strong>Conclusion: </strong>The benefits of 3D printing in orthopaedic surgery, including improved visualization, reduced time, and improved precision, highlight its potential for further advancement.</p>","PeriodicalId":51129,"journal":{"name":"Medicinski Glasnik","volume":"22 1","pages":"111-114"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143701438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Knowledge and practice of intermittent fasting: a cross-sectional study among university students in the United Arab Emirates.","authors":"Sarah Imran Zahid, Mahnoor Dilawar, Fatima Garba Tahir, Tala Tarek Mousa, Nadia Imran Zahid, Jayadevan Sreedharan","doi":"10.17392/1898-22-01","DOIUrl":"https://doi.org/10.17392/1898-22-01","url":null,"abstract":"<p><strong>Aim: </strong>Intermittent fasting is a popular weight loss strategy that alternates between fasting periods and unrestricted eating. Research shows it can improve insulin resistance, lower HbA1c level, aid in weight management, and enhance cardiometabolic health. These effects can help address obesity, hypertension, and type 2 diabetes. Despite its popularity, research on intermittent fasting in the United Arab Emirates is sparse. This study aimed to evaluate the awareness and practice of different intermittent fasting regimens, including Alternate-Day Fasting, Modified Fasting, Time-Restricted Feeding, Ramadan Fasting, and Chinese Medical Nutrition Therapy, as well as to examine the relationship between intermittent fasting and obesity, hypertension, and type 2 diabetes.</p><p><strong>Methods: </strong>A cross-sectional study was conducted with 320 participants aged ≥18 years, irrespective of gender or nationality. An approval was obtained from the Institutional Review Board, and informed consent was secured. Data were collected via a validated questionnaire on Google Forms, covering sociodemographic details, knowledge and practice of intermittent fasting, information sources, and health conditions.</p><p><strong>Results: </strong>A total of 270 (87.4%) of participants were aware of intermittent fasting, and 149 (55.2%) practiced it. There was no significant link between knowledge and practice, but 29 (78.4%) of practitioners associated intermittent fasting with obesity. Among those with chronic conditions, 23 (91.2%) experienced positive changes.</p><p><strong>Conclusion: </strong>Despite the high awareness of intermittent fasting, individual beliefs influence its practice. The identified association between obesity and positive changes in those with chronic conditions implies potential benefits.</p>","PeriodicalId":51129,"journal":{"name":"Medicinski Glasnik","volume":"22 1","pages":"145-150"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143702032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Predictive factors for biochemical relapse in non-metastatic prostate cancer following primary radiotherapy.","authors":"Amila Kovčić, Šefika Umihanić, Hasan Osmić, Almedina Muhić, Enida Trumić, Eldar Hamzić, Emir Bećirović, Semir Hadžić, Amir Bećirović, Minela Bećirović, Emir Begagić","doi":"10.17392/1796-22-01","DOIUrl":"https://doi.org/10.17392/1796-22-01","url":null,"abstract":"<p><strong>Aim: </strong>To investigate the predictors of biochemical relapse (BCR) among patients with non-metastatic prostate cancer treated with radiotherapy as the first-line therapy.</p><p><strong>Methods: </strong>The study included 91 patients diagnosed with prostate cancer at the University Clinical Centre in Tuzla, Bosnia and Herzegovina. After the radiation treatment as the first line of treatment, the patients were monitored for the next 36 months. If patients were classified in medium and high-risk groups, hormone therapy was administered. The occurrence of BCR was determined based on prostate-specific antigen (PSA) values. Potential prognostic parameters, including Gleason score (GS), PSA, tumour size (TNM), and standardised risk classification (RC), were monitored.</p><p><strong>Results: </strong>A total of 46 (50.5%) patients were aged 66-75, with a median PSA of 14.50 ng/mL. A Gleason score <6 was found in 72 (79.1%) of patients, and 31 (34.1%) had T2c tumours. The BCR occurred in 32 (35.2%) patients, with a median relapse time of 18 months. Significant predictors of BCR were Gleason score ≥6 (OR:4.46; p=0.006) and tumour stage >T2b (OR:3.59; p=0.021). The RC showed an Area Under Curve (AUC) of 0.634 (p=0.050), indicating its potential diagnostic accuracy.</p><p><strong>Conclusion: </strong>Gleason score ≥6 and TNM>T2b are significant predictors of biochemical relapse in prostate cancer patients treated with radiotherapy. These results emphasize the need for additional monitoring and timely treatment of clinical disease progression in patients with Gleason score ≥6 and tumour stage >T2b.</p>","PeriodicalId":51129,"journal":{"name":"Medicinski Glasnik","volume":"22 1","pages":"83-87"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143702118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The significance of individual patient characteristics in a cohort of patients with inflammatory bowel disease treated with vedolizumab.","authors":"Nadža Zubčević, Mirela Bašić-Denjagić, Emil Babic, Tatjana Barač, Aida Saray, Nerma Čustović","doi":"10.17392/1770-22-01","DOIUrl":"https://doi.org/10.17392/1770-22-01","url":null,"abstract":"<p><strong>Aim: </strong>Care for the inflammatory bowel disease (IBD) patients presents unique challenges as decisions regarding therapy must consider numerous distinct characteristics of each patient. The aim of the study was to recognize patients' characteristics as predictors of success in vedolizumab treatment.</p><p><strong>Methods: </strong>In a retrospective observational study, data regarding age, gender, body mass index (BMI), length of disease, previous exposure to anti-tumour necrosis factor (TNF), drugs, and smoking status were extracted from the routine clinical practice. Patients were assessed for clinical remission and steroid-free remission after the 26-week treatment with vedolizumab.</p><p><strong>Results: </strong>The study included 76 patients with UC and 63 with CD. A total of 63 (out of 76; 82.9%) (Cl: 72.5-90.6% ) of UC and 54 (out of 63; 85.7%) (Cl: 74.6-93.3%) CD patients achieved clinical remission in the 26-week vedolizumab treatment. Over five years, illness was noticed in 32 (53.1%) CD patients. Clinical remission was not achieved in six (out of 13; 46.1%) UC patients aged 40-49 years and six (out of nine; 66.6%) CD patients aged 30-49 years. Among CD patients, remission was achieved in 22 (85.7%) females and 23 (63.6%) males. Remission rates were generally higher in patients with a BMI of 18.6-25 and 25.1-30. Previous exposure to anti TNF drugs and smoking status did not influence treatment outcomes.</p><p><strong>Conclusion: </strong>The efficacy of vedolizumab is a viable treatment option for both ulcerative colitis and Crohn's disease. The exploration of individual patient characteristics holds promise in predicting a treatment outcome.</p>","PeriodicalId":51129,"journal":{"name":"Medicinski Glasnik","volume":"22 1","pages":"53-58"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143702167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Approaches to rhythm control: Impact of electrical cardioversion versus pharmacological management on left atrial size and systolic performance in atrial fibrillation and flutter.","authors":"Emir Bećirović, Minela Bećirović, Amir Bećirović, Lejla Tupković Rakovac, Amira Jagodić Ejubović, Begajeta Čaušević, Malik Ejubović, Aida Ribić, Lamija Ferhatbegović, Ammar Brkić, Semir Hadžić, Maida Skokić, Emir Begagić","doi":"10.17392/1830-22-01","DOIUrl":"https://doi.org/10.17392/1830-22-01","url":null,"abstract":"<p><strong>Aim: </strong>To compare the impact of electrical cardioversion (ECV) and pharmacological cardioversion (PCV) on left atrial size (LA) and left ventricular ejection fraction (LVEF), as well as to identify predictors of rhythm disorder recurrence in patients with atrial fibrillation (AF) or atrial flutter (AFL).</p><p><strong>Methods: </strong>A prospective observational cohort study was conducted on 105 patients with persistent AF or AFL at the University Clinical Centre Tuzla. The patients were divided into two groups: 53 underwent ECV and 52 received PCV. Demographic and clinical data, including ECG and transthoracic echocardiography, were collected. Follow-up assessments were conducted at 7 days, 1 month, and subsequently every 3 months for a year.</p><p><strong>Results: </strong>Baseline characteristics were similar between the groups. Recurrence of rhythm disorder within one year was observed in 52.4% of cases, with ECV showing a slightly lower, though not significantly different, primary failure rate at 7 days compared to PCV (13.2% vs. 23.1%). Significant predictors of recurrence included longer duration of disorder (p< 0.001), hypertension (p=0.016), lack of pre-cardioversion amiodarone (p=0.027), and larger LA (p< 0.001). Both ECV and PCV significantly reduced LA over time, with no significant differences in LVEF between groups.</p><p><strong>Conclusion: </strong>Both ECV and PCV are effective in restoring sinus rhythm, with a trend towards lower recurrence in the ECV group. Predictors such as disorder duration, hypertension, lack of pre-cardioversion amiodarone, and LA should be considered when planning cardioversion to optimize patient outcomes.</p>","PeriodicalId":51129,"journal":{"name":"Medicinski Glasnik","volume":"22 1","pages":"26-32"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143702084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Bariatric surgery in University Clinical Centre Tuzla and Bosnia and Herzegovina: where we are and where we want to be.","authors":"Fuad Pašić, Nermin Salkić, Emir Ahmetašević, Ervin Alibegović, Jasmina Smajić, Lejla Jašarević, Rusmir Softić, Jasmin Hamidović, Amina Krupalija","doi":"10.17392/1868-22-01","DOIUrl":"https://doi.org/10.17392/1868-22-01","url":null,"abstract":"<p><p>Bariatric surgery has emerged as the most effective treatment for morbid obesity, offering substantial and sustained weight loss and improvement in comorbid conditions. This paper reviews the development, implementation, and outcomes of bariatric surgery at the University and Clinical Centre Tuzla based on a retrospective analysis of patients who underwent bariatric surgery over a three-year period. A significant weight loss was observed, postoperative complications were minimal, with no in-hospital mortality. The bariatric surgery program demonstrates a significant progress in treating morbid obesity in Bosnia and Herzegovina.</p>","PeriodicalId":51129,"journal":{"name":"Medicinski Glasnik","volume":"22 1","pages":"1-3"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143702085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Heart and kidney crosstalk: risk factors, clinical features, and short-term outcomes associated with acute kidney injury in patients suffering acute non-ST elevation myocardial infarction.","authors":"Minela Bećirović, Emir Bećirović, Semir Hadžić, Lejla Rakovac Tupković, Amir Bećirović, Nadina Avdić Jahić, Aida Ribić, Lamija Ferhatbegović, Amira Jagodić Ejubović, Emir Begagić, Daniela Lončar, Kenana Ljuca","doi":"10.17392/1776-22-01","DOIUrl":"https://doi.org/10.17392/1776-22-01","url":null,"abstract":"<p><strong>Aim: </strong>Acute kidney injury (AKI) presents a high mortality complication in patients with acute myocardial infarction (AMI). Yet, its correlation with non-ST elevation myocardial infarction (NSTEMI) remains neglected in the literature. This study aims to investigate the prevalence, risk factors, clinical features, and short-term outcomes associated with AKI development in patients with acute NSTEMI.</p><p><strong>Methods: </strong>A one-year prospective observational cohort study involved 170 consecutive patients hospitalized in the Intensive Care Department of the Internal Medicine Clinic at the University Clinical Centre Tuzla diagnosed with acute NSTEMI. Patients were subsequently categorized into AKI and non-AKI groups based on AKI development within 48 hours. Demographic characteristics, laboratory findings, and short-term clinical outcomes were compared between the groups.</p><p><strong>Results: </strong>Of 170 patients, 31 (18.2%) developed AKI within 48 hours of acute NSTEMI. Significant age differences, blood urea nitrogen (BUN), creatinine, estimated glomerular filtration rate (eGFR), blood glucose level (BGL), C-reactive protein (CRP), and high sensitivity (hs) troponin were observed, making patients with lower baseline kidney function, more extensive myocardial infarction, and a heavier systemic inflammatory response following acute NSTEMI more susceptible to AKI development. In the follow-up period, mortality rates were significantly higher in the AKI group, amounting to 35.5% compared to 10.1% in the non-AKI group. Additionally, mortality increased with the severity of AKI, reaching 100% in AKI stage 2.</p><p><strong>Conclusion: </strong>This study highlights demographic, clinical and laboratory findings in patients with acute NSTEMI, which contribute to AKI development. Early detection and tailored interventions are crucial in mitigating AKI-associated morbidity and mortality.</p>","PeriodicalId":51129,"journal":{"name":"Medicinski Glasnik","volume":"22 1","pages":"20-25"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143702005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of lung ultrasound-guided therapeutic approach on haemodialysis treatment in patients with ischemic heart failure.","authors":"Nejra Prohić, Belma Paralija, Halma Resić, Edin Begić","doi":"10.17392/1847-22-01","DOIUrl":"https://doi.org/10.17392/1847-22-01","url":null,"abstract":"<p><strong>Aim: </strong>Lung ultrasound (LUS) can be used for an assessment of volume overload in patients with end-stage kidney disease (ESKD) and those undergoing dialysis. The aim of this study was to analyse whether the initial use of LUS in evaluating volume status could benefit patients by optimizing haemodialysis treatment and improving their clinical status.</p><p><strong>Methods: </strong>The study included 50 haemodialysis patients in stage V of ESKD with the diagnosis of ischaemic heart failure with reduced (HFrEF) or midrange ejection fraction (HFmrEF). The assessment of volume status was verified solely by LUS (along with the analysis of B lines as measures of volume status). The specified laboratory parameters were performed initially, after three, and after six months.</p><p><strong>Results: </strong>The number of B-lines on LUS were decreased during the six-month follow-up compared to baseline, indicating a reduction in volume overload due to the LUS-guided protocol. Statistically significant differences were observed in the average creatinine (p=0.001) and parathormone (PTH) (p=0.003) levels over the six-month monitoring period. Significant differences were also noted in triglyceride (p=0.000) and potassium (p=0.02) levels. No significant differences were found in the values of other monitored parameters.</p><p><strong>Conclusion: </strong>In haemodialysis patients diagnosed with heart failure, LUS can aid the achievement of a more efficient volume reduction by decreasing B-lines, which are indicative of congestion. Our study also demonstrated beneficial effects of LUS on potassium and parathormone levels.</p>","PeriodicalId":51129,"journal":{"name":"Medicinski Glasnik","volume":"22 1","pages":"43-47"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143701949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}